Home›Companies›Biotech & Pharma›ClearNote Health

ClearNote Health, Inc.

Updated Oct 27, 2026·Latest SEC filing Jun 5, 2025·Suggest an edit

About ClearNote Health

ClearNote Health is a private company based in San Diego, California. It has reported $91,106,038 raised in two offerings on Form D since June 2021. Its chief executive is David Mullarkey.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 27, 2025Jun 5, 2025$21,784,827of $60.5M target5$4.3MEquity, Options, Offering of Series D Preferred Stock and Series D-1 Preferred Stock (collectively "Series D"), warrants to purchase Series D and the underlying shares of Common Stock issuable upon conversion of Series D.Rule 506(b)Form D ↗
Mar 20, 2019Jun 21, 2021$69,321,211of $71.6M target14$4.9MEquity, Offering of Series C Preferred Stock ("Series C") and the underlying shares of Common Stock issuable upon conversion of Series C.Rule 506(b)Form D ↗
Total, two offerings$91,106,038

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ClearNote Health's Form D filed Jun 5, 2025.

TN
Tina Nova
Director
DM
David Mullarkey
Chief Executive Officer and director
SL
Samuel Levy
Executive officer
JW
SQ

Earlier filings also listed Johan Westerman (director, last listed Jun 2021).

Sources

  1. SECClearNote Health, Inc. filing history